FDA Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations)

The Orange Book is a critical regulatory resource officially titled 'Approved Drug Products with Therapeutic Equivalence Evaluations.' It is a publication produced and maintained by the United States government to provide information on pharmaceutical drug products. It specifically lists drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.

Originally established to address the need for a list of approved drugs and their generic equivalents, the Orange Book has become the gold standard for pharmacists, physicians, and lawyers in determining therapeutic equivalence. The publication includes information on patents and market exclusivity, serving as a vital legal and commercial reference in the pharmaceutical industry. While it began as a physical printed publication with an orange cover, it is now primarily accessed as a searchable digital database managed by the Center for Drug Evaluation and Research.

The 'Orange Book store' typically refers to the public interface or distribution point through which the FDA or authorized government printing offices provide these records. Ownership and maintenance remain strictly under the jurisdiction of the U.S. Federal Government, ensuring that the data remains unbiased and authoritative for public health and safety.